| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000004980 |
| Receipt No. | R000005920 |
| Official scientific title of the study | Basic analysis of tear/aqueous humor/vitreous fluid/ retinochoroidal tissue/sclera for Chorioretinopathy |
| Date of disclosure of the study information | 2011/01/30 |
| Last modified on | 2017/03/29 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Basic analysis of tear/aqueous humor/vitreous fluid/ retinochoroidal tissue/sclera for Chorioretinopathy | |
| Title of the study (Brief title) | analysis of tear/aqueous humor/Vitreous fluid/ retinochoroidal tissue/sclera | |
| Region |
|
|
| Condition | ||
| Condition | Chorioretinopathy(include uveitis), diabetic retinopathy, scleritis, retinal detachment, retinal vein occlusion, malignant lymphoma, epiretinal membrane | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Tissue from horioretinopathy(include uveitis), diabetic retinopathy, scleritis, retinal detachment, retinal vein occlusion, malignant lymphoma, epiretinal membrane were collected during operation, which should become the useful tool for curing the disease. Collected samples were tested by several basic analysis such as real time PCR, ELISA, western blotting and tissue specimen. The sample of vitreous fluid were collected by vitrectomy with using 23 gage or 25 gage needles. The other tissue were collected by scissors. After that, laser treatment apply for spots of dissected area. We investigate the new findings and treatment for the disease that dose not have any effective treatment. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | We would not develop the drugs and new treatment method. So, we could not asses from this clinical test. We could asses and hold the clinical condition from the tissue that was collected during operation. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who suffered from vitreous opacification, retinal detach, the proliferative change of retina need the operation to cure those disease. | |||
| Key exclusion criteria | normal condition | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuichi Maruyama |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Ophthalmology |
| Address | 1-1 Seiryo-machi Aobaku, Sendai |
| TEL | 022-717-7294 |
| maruyama-k@oph.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Kazuichi Maruyama |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Ophthalmology |
| Address | 1-1 Seiryo-machi Aobaku, Sendai |
| TEL | 022-717-7294 |
| Homepage URL | |
| maruyama-k@oph.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Tohoku University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tohoku University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | RBMR-61807 |
| Org. issuing International ID_1 | Kyoto Prefectural University of Medicine |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 京都府立医科大学附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | We performed 87 subject of 150 scheduled subjects at Tohoku University Hospital. In our examination, we noticed that sarcoidosis and lymphoma had signature T cell and B cell population in uveitis. |
| Other related information | The tissue collected from patients randomly and prepare for histological section, to detect the infection with using PCR, analyze the cell population. This test perform as forward looking research to detect the relationship between the results and pathogenesis. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005920 |